Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
GALT
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
GALT: Galectin Therapeutics Inc. Stock Analysis | finqOS
GALT
$2.69
−4.27%
Lists
Call GALT
Galectin Therapeutics
GALT
Back
Lists
Call GALT
$2.69
−$0.12 · −4.27%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
27%
in three months and
13%
of the way up its 52-week range.
Call GALT
Loading chart data...
Signal state